mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
SB52334 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.095 |
0.004 |
mRNA |
HC-067047 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
Midostaurin |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
0.005 |